Welcome to LookChem.com Sign In|Join Free

CAS

  • or
L-Threonic acid calcium salt is a naturally occurring compound derived from L-Threonic acid, which can be found in the leaves of Pelargonium crispum. It is also a degradation product of Dehydroascorbate (DHA), a metabolite of Vitamin C (A786990).

70753-61-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 70753-61-6 Structure
  • Basic information

    1. Product Name: L-Threonic acid calcium salt
    2. Synonyms: (2R,3S)-2,3,4-TRIHYDROXYBUTYRIC ACID HEMICALCIUM SALT;L-THREONIC ACID CALCIUM SALT;L-THREONIC ACID HEMICALCIUM SALT;CALCIUM L-THREONATE;L-Threonic Acid Calcium;L-threonic acid hemicalciumsalz;L-Threonic acid calcium salt, (2R,3S)-2,3,4-Trihydroxybutyric acid hemicalcium salt;L-Threonic acid hemicalcium salt,(2R,3S)-2,3,4-Trihydroxybutyric acid hemicalcium salt, L-Threonic acid calcium salt
    3. CAS NO:70753-61-6
    4. Molecular Formula: 2C4H7O5*Ca
    5. Molecular Weight: 310.27
    6. EINECS: 1312995-182-4
    7. Product Categories: Ca (Calcium) Compounds;Classes of Metal Compounds;Typical Metal Compounds
    8. Mol File: 70753-61-6.mol
  • Chemical Properties

    1. Melting Point: >300 °C(lit.)
    2. Boiling Point: 518.9oC at 760 mmHg
    3. Flash Point: 281.7oC
    4. Appearance: Pale Brown/Powder
    5. Density: N/A
    6. Vapor Pressure: 6.17E-13mmHg at 25°C
    7. Refractive Index: 15 ° (C=1, H2O)
    8. Storage Temp.: Inert atmosphere,Room Temperature
    9. Solubility: DMSO (Slightly), Water (Slightly, Heated)
    10. Water Solubility: Soluble in water. Sparingly soluble in methanol.
    11. BRN: 5166008
    12. CAS DataBase Reference: L-Threonic acid calcium salt(CAS DataBase Reference)
    13. NIST Chemistry Reference: L-Threonic acid calcium salt(70753-61-6)
    14. EPA Substance Registry System: L-Threonic acid calcium salt(70753-61-6)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 22-24/25-37/39-26
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 70753-61-6(Hazardous Substances Data)

70753-61-6 Usage

Uses

Used in Pharmaceutical Industry:
L-Threonic acid calcium salt is used as a pharmaceutical ingredient for its potential therapeutic applications. As a degradation product of Vitamin C, it may contribute to the development of new drugs or supplements that can benefit from its unique properties.
Used in Nutritional Supplements:
L-Threonic acid calcium salt is used as an additive in the nutritional supplement industry due to its connection with Vitamin C metabolism. It may be incorporated into products that aim to support immune function, skin health, and overall well-being.
Used in Agricultural Applications:
L-Threonic acid calcium salt can be utilized in the agricultural sector as a natural component that may enhance plant growth and health. Its presence in the leaves of Pelargonium crispum suggests potential benefits when used as a supplement in plant cultivation.
Used in Research and Development:
L-Threonic acid calcium salt serves as a valuable compound for research and development in various scientific fields, including biochemistry, pharmacology, and nutrition. Its study can lead to a better understanding of its properties and potential applications in different industries.

Check Digit Verification of cas no

The CAS Registry Mumber 70753-61-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,7,5 and 3 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 70753-61:
(7*7)+(6*0)+(5*7)+(4*5)+(3*3)+(2*6)+(1*1)=126
126 % 10 = 6
So 70753-61-6 is a valid CAS Registry Number.
InChI:InChI=1/2C4H8O5.Ca/c2*5-1-2(6)3(7)4(8)9;/h2*2-3,5-7H,1H2,(H,8,9);/q;;+2/p-2/t2*2-,3+;/m00./s1

70753-61-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (380644)  L-Threonicacidhemicalciumsalt  >97%

  • 70753-61-6

  • 380644-5G

  • 2,628.99CNY

  • Detail

70753-61-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name L-Threonic Acid Calcium Salt

1.2 Other means of identification

Product number -
Other names L-Threonic acid calcium salt

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:70753-61-6 SDS

70753-61-6Synthetic route

ascorbic acid
50-81-7

ascorbic acid

calcium L-threonate
70753-61-6

calcium L-threonate

Conditions
ConditionsYield
With dihydrogen peroxide; calcium carbonate In water at 5 - 70℃; for 18h;94.6%
Stage #1: ascorbic acid With calcium carbonate In water at 0 - 5℃;
Stage #2: With dihydrogen peroxide In water at 5 - 75℃; for 18h;
Stage #3: With methanol In water at 20 - 50℃; for 12h;
94.6%
With dihydrogen peroxide; calcium carbonate In water at 0 - 20℃; for 18h;85%
calcium L-threonate
70753-61-6

calcium L-threonate

L-threonic acid-4-lactone
21730-93-8

L-threonic acid-4-lactone

Conditions
ConditionsYield
With oxalic acid; toluene-4-sulfonic acid In acetonitrile for 3h; Reflux;94%
With oxalic acid; toluene-4-sulfonic acid In acetonitrile Reflux;93%
methanol
67-56-1

methanol

calcium L-threonate
70753-61-6

calcium L-threonate

methyl 2,4-dibromo-2,4-dideoxy-L-erythronate
88824-11-7

methyl 2,4-dibromo-2,4-dideoxy-L-erythronate

Conditions
ConditionsYield
Stage #1: calcium L-threonate With hydrogen bromide; acetic acid for 24h;
Stage #2: methanol Heating;
90.2%
Stage #1: calcium L-threonate With hydrogen bromide In acetic acid for 24h;
Stage #2: methanol In acetic acid at 20℃; for 14h; Reflux;
90.2%
With hydrogen bromide 1.) acetic acid, room temperature, 24 h, 2.) boiled, 2 h; Yield given. Multistep reaction;
O-benzylhydoxylamine hydrochloride
2687-43-6

O-benzylhydoxylamine hydrochloride

calcium L-threonate
70753-61-6

calcium L-threonate

L-threonic acid (benzyloxy)amide
97764-61-9

L-threonic acid (benzyloxy)amide

Conditions
ConditionsYield
With sodium hydrogencarbonate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In water for 4h;72.4%
benzoyl chloride
98-88-4

benzoyl chloride

calcium L-threonate
70753-61-6

calcium L-threonate

2′,3′-di-O-benzoyl-L-threonolactone
538368-86-4

2′,3′-di-O-benzoyl-L-threonolactone

Conditions
ConditionsYield
Stage #1: calcium L-threonate With Dowex 50WX4-50 In water at 70℃; for 0.5h;
Stage #2: With toluene-4-sulfonic acid In acetonitrile for 1h; Heating;
Stage #3: benzoyl chloride With pyridine at 20℃; for 10h;
60%
benzoyl chloride
98-88-4

benzoyl chloride

calcium L-threonate
70753-61-6

calcium L-threonate

2′-O-benzoyl-L-threonolactone
91345-19-6

2′-O-benzoyl-L-threonolactone

Conditions
ConditionsYield
Stage #1: calcium L-threonate In water at 70℃; for 0.5h;
Stage #2: With toluene-4-sulfonic acid In acetonitrile for 23h; Reflux;
Stage #3: benzoyl chloride With 1H-imidazole In acetonitrile at 0 - 20℃;
45%
calcium L-threonate
70753-61-6

calcium L-threonate

(2S,3S)-2,4-Dibromo-3-hydroxy-butyric acid
117069-13-3

(2S,3S)-2,4-Dibromo-3-hydroxy-butyric acid

Conditions
ConditionsYield
With hydrogen bromide; acetic anhydride; acetic acid for 24h; Ambient temperature;
With hydrogen bromide In acetic acid for 1.5h; Ambient temperature;
methanol
67-56-1

methanol

calcium L-threonate
70753-61-6

calcium L-threonate

methyl (2R,3S)-2,3,4-trihydroxybutanoate
137460-62-9

methyl (2R,3S)-2,3,4-trihydroxybutanoate

Conditions
ConditionsYield
With hydrogenchloride at 37℃; for 120h;
calcium L-threonate
70753-61-6

calcium L-threonate

L-threonic acid
7306-96-9

L-threonic acid

Conditions
ConditionsYield
With Amberlite IR-120 In water at 50℃;

70753-61-6Upstream product

70753-61-6Relevant articles and documents

Selective Prebiotic Synthesis of α-Threofuranosyl Cytidine by Photochemical Anomerization

Colville, Ben W. F.,Powner, Matthew W.

supporting information, p. 10526 - 10530 (2021/03/30)

The structure of life's first genetic polymer is a question of intense ongoing debate. The “RNA world theory” suggests RNA was life's first nucleic acid. However, ribonucleotides are complex chemical structures, and simpler nucleic acids, such as threose nucleic acid (TNA), can carry genetic information. In principle, nucleic acids like TNA could have played a vital role in the origins of life. The advent of any genetic polymer in life requires synthesis of its monomers. Here we demonstrate a high-yielding, stereo-, regio- and furanosyl-selective prebiotic synthesis of threo-cytidine 3, an essential component of TNA. Our synthesis uses key intermediates and reactions previously exploited in the prebiotic synthesis of the canonical pyrimidine ribonucleoside cytidine 1. Furthermore, we demonstrate that erythro-specific 2′,3′-cyclic phosphate synthesis provides a mechanism to photochemically select TNA cytidine. These results suggest that TNA may have coexisted with RNA during the emergence of life.

MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS

-

Paragraph 0194, (2017/05/07)

A composition for administration to a subject, such as oral administration to a subject, for example, has been provided. Such a composition may comprise at least one magnesium-counter ion compound. A magnesium-counter ion composition described herein may be useful for any of a variety of applications provided herein, such as maintaining, enhancing, and/or improving health, nutrition, and/or another condition of a subject, and/or cognitive, learning, and/or memory function. A magnesium-counter ion composition provided herein may be useful for administration to a subject presenting magnesium deficiency, mild cognitive impairment, Alzheimer's disease, attention deficit hyperactivity disorder, ALS, Parkinson's disease, diabetes, migraine, anxiety disorder, mood disorder, and/or hypertension. A kit, method, and other associated technology are also provided.

A Scalable Synthesis of α-L-Threose Nucleic Acid Monomers

Sau, Sujay P.,Fahmi, Nour Eddine,Liao, Jen-Yu.,Bala, Saikat,Chaput, John C.

, p. 2302 - 2307 (2016/04/04)

Recent advances in polymerase engineering have made it possible to copy information back and forth between DNA and artificial genetic polymers composed of TNA (α-l-threofuranosyl-(3′,2′) nucleic acid). This property, coupled with enhanced nuclease stability relative to natural DNA and RNA, warrants further investigation into the structural and functional properties of TNA as an artificial genetic polymer for synthetic biology. Here, we report a highly optimized chemical synthesis protocol for constructing multigram quantities of TNA nucleosides that can be readily converted to nucleoside 2′-phosphoramidites or 3′-triphosphates for solid-phase and polymerase-mediated synthesis, respectively. The synthetic protocol involves 10 chemical transformations with three crystallization steps and a single chromatographic purification, which results in an overall yield of 16-23% depending on the identity of the nucleoside (A, C, G, T).

NOVEL ANTIVIRAL COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND THEIR USE FOR TREATING VIRAL INFECTIONS

-

Page/Page column 20; 21, (2017/01/05)

The present invention relates to novel pro-drugs of L-2'-deoxythreose nucleoside phosphonates, such as phosphoramidate, phosphorodiamidate and phospho-diester prodrugs. The invention also relates to a process for preparing these novel prodrugs of nucleoside phosphonates. The invention also relates to the use of these novel phosphonatemodified nucleosides to treat or prevent viral infections and their use to manufacture a medicine to treat or prevent viral infections, particularly infections with viruses belonging to the HBV family.

Nonenzymatic oligomerization of RNA by TNA templates

Heuberger, Benjamin O.,Switzer, Christopher

, p. 5809 - 5811 (2007/10/03)

(Diagram presented) Cytosine TNA promotes nonenzymatic, template-directed oligomerization of complementary activated rGMP, leading to selective and efficient formation of RNA products. This process models "genetic takeover" of a pre-RNA by RNA.

Method for synthesizing oxazinones

-

Page 16, (2010/02/06)

New methods and intermediates are discussed for the stereospecific synthesis of oxazinone compounds.

Cyclic hydroxamates, especially multiply substituted [1,2]oxazinan-3-ones

Wolfe, Saul,Wilson, Marie-Claire,Cheng, Ming-Huei,Shustov, Gennady V.,Akuche, Christiana I.

, p. 937 - 960 (2007/10/03)

Routes to putative N-acyl-D-ala-D-ala surrogates, beginning with the conversion of 4-, 5-, and 6-membered lactones into 5-, 6-, and 7-membered cyclic hydroxamates, are reported. The key step of the synthesis is trimethylaluminium-promoted cyclization of an ω-aminooxyester. The 7-membered cyclic hydroxamate crystallizes in a chair conformation. Extension of the reaction sequence to homoserine or homoserine lactone leads to cyclocanaline and N-acylated cyclocanalines. The 4-phenylacetamido derivative of cyclocanaline crystallizes in a boat conformation. The attachment of a 2-carboxypropyl substituent to the ring nitrogen of a 4-acylaminocyclocanaline has been effected, prior to cyclization, by coupling of the acyclic aminooxyester precursor to the triflate of benzyl lactate or, after cyclization, by coupling to tert-butyl α-bromopropionate in the presence of potassium fluoride - alumina, followed by removal of the protecting group in each case. A six-membered homolog of the antibiotic lactivicin has been synthesized by the reaction of 4-phenylacetamidocyclocanaline with benzyl 2-oxoglutarate in the presence of carbodiimide, followed by hydrogenolysis. Starting with methyl 2,4-dibromo-2,4-dideoxy-L-erythronate, which is available in two steps from L-ascorbic acid, these reaction sequences have been applied to the stereospecific synthesis of a D-alanine derivative whose nitrogen atom is enclosed within a 3,4-disubstituted [1,2]oxazinan-3-one.

The α-L-Threofuranosyl-(3′ → 2′)-oligonucleotide system ('TNA'): Synthesis and pairing properties

Schoening, Kai-Uwe,Scholz, Peter,Wu, Xiaolin,Guntha, Sreenivasulu,Delgado, Guillermo,Krishnamurthy, Ramanarayanan,Eschenmoser, Albert

, p. 4111 - 4153 (2007/10/03)

Our studies of α-L-Threofuranosyl-(3′ → 2′)-oligonucleotides ('TNA') are part of a systematic experimental inquiry into the base-pairing properties of potentially natural nucleic acid alternatives taken from RNA's close structural neighborhood. TNA is an efficient Watson-Crick base-pairing system and has the capability of informational cross-pairing with both RNA and DNA. This property, together with the system's constitutional and (presumed) generational simplicity, warrants special scrutiny of TNA in the context of the search for chemical clues to RNA's origin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 70753-61-6